SV2001000212A - Una combinacion de agentes antineoplasticos que comprenden acetildinalina y paclitaxel y/o carboplatina y juego que la comprende - Google Patents

Una combinacion de agentes antineoplasticos que comprenden acetildinalina y paclitaxel y/o carboplatina y juego que la comprende

Info

Publication number
SV2001000212A
SV2001000212A SV2000000212A SV2000000212A SV2001000212A SV 2001000212 A SV2001000212 A SV 2001000212A SV 2000000212 A SV2000000212 A SV 2000000212A SV 2000000212 A SV2000000212 A SV 2000000212A SV 2001000212 A SV2001000212 A SV 2001000212A
Authority
SV
El Salvador
Prior art keywords
acetildinaline
carboplatin
paclitaxel
combination
game
Prior art date
Application number
SV2000000212A
Other languages
English (en)
Inventor
Ronald Lynn Merriman
Wayne Daniel Klohs
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV2001000212A publication Critical patent/SV2001000212A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA ACETILDINALINA EN COMBINACIÓN CON PACLITAXEL Y/O CARBOPLATINA ES SINERGISTICA PARA TRATAR EL CANCER.
SV2000000212A 1999-11-10 2000-11-07 Una combinacion de agentes antineoplasticos que comprenden acetildinalina y paclitaxel y/o carboplatina y juego que la comprende SV2001000212A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16488999P 1999-11-10 1999-11-10
US22256100P 2000-08-03 2000-08-03

Publications (1)

Publication Number Publication Date
SV2001000212A true SV2001000212A (es) 2001-10-25

Family

ID=26860956

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2000000212A SV2001000212A (es) 1999-11-10 2000-11-07 Una combinacion de agentes antineoplasticos que comprenden acetildinalina y paclitaxel y/o carboplatina y juego que la comprende

Country Status (17)

Country Link
EP (1) EP1229916A2 (es)
JP (1) JP2003513912A (es)
KR (1) KR20020060226A (es)
CN (1) CN1387438A (es)
AR (1) AR026400A1 (es)
AU (1) AU1583201A (es)
CA (1) CA2386876A1 (es)
GT (1) GT200000194A (es)
HU (1) HUP0203153A3 (es)
IL (1) IL149363A0 (es)
NZ (1) NZ518668A (es)
PA (1) PA8506201A1 (es)
PE (1) PE20011028A1 (es)
PL (1) PL355170A1 (es)
SV (1) SV2001000212A (es)
UY (1) UY26431A1 (es)
WO (1) WO2001034131A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
PE20050206A1 (es) * 2003-05-26 2005-03-26 Schering Ag Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
CA2552279C (en) * 2003-12-02 2014-07-15 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
US7951780B2 (en) 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
EP2322217A3 (en) * 2004-07-16 2011-09-28 Pfizer Products Inc. Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody
PL2415382T3 (pl) 2010-08-06 2013-02-28 Electrolux Home Products Corp Nv Zmywarka nablatowa
EP3461480A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
EP3461488A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dbait molecule and a hdac inhibitor for treating cancer
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2023041805A1 (en) 2021-09-20 2023-03-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2023194441A1 (en) 2022-04-05 2023-10-12 Istituto Nazionale Tumori Irccs - Fondazione G. Pascale Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases

Also Published As

Publication number Publication date
WO2001034131A2 (en) 2001-05-17
AU1583201A (en) 2001-06-06
GT200000194A (es) 2002-05-03
HUP0203153A2 (hu) 2003-01-28
CN1387438A (zh) 2002-12-25
IL149363A0 (en) 2002-11-10
PL355170A1 (en) 2004-04-05
PE20011028A1 (es) 2001-10-12
UY26431A1 (es) 2000-12-29
EP1229916A2 (en) 2002-08-14
AR026400A1 (es) 2003-02-12
NZ518668A (en) 2004-04-30
PA8506201A1 (es) 2002-12-11
KR20020060226A (ko) 2002-07-16
WO2001034131A3 (en) 2002-05-10
JP2003513912A (ja) 2003-04-15
HUP0203153A3 (en) 2005-01-28
CA2386876A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
FR2869231B1 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
NO20054988D0 (no) Preparater og metoder for behandling av cancer
CR11486A (es) Tratamiento de cancer uterino y cancer de ovario con un inhibidor de parp solo o en combinacion con agentes anti-tumorales
SV2001000212A (es) Una combinacion de agentes antineoplasticos que comprenden acetildinalina y paclitaxel y/o carboplatina y juego que la comprende
MXPA05012421A (es) Tratamiento sinergistico de cancer usando inmunomeros junto con agentes quimioterapeuticos.
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
AR023616A1 (es) Preparaciones combinadas que comprenden derivados de antraciclina
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
ES2184341T3 (es) Un metodo para la prevencion y el tratamiento de la disfuncion del miocardio.
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
ES2159357T3 (es) Derivados terpenoides (sarcodictinas) utiles como agentes antitumorales.
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia
ATE294585T1 (de) Vorbeugung von kolorektalkrebs
AR029958A1 (es) Uso de fosfato de estramustina en el tratamiento de metastasis osea y en el tratamiento de metastasis osea en pacientes con cancer de prostata
RS50681B (sr) Kombinacija taksana i ciklin-zavisne kinaze
PT1273296E (pt) Combinacao de acetildinalina e docetaxel
ECSP003755A (es) Quimioterapia de combinacion
DOP2000000092A (es) Quimioterapia de combinación
AR027677A1 (es) Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer
DE60143681D1 (de) Kombinationstherapie gegen Tumoren mit substituierten Acryloyl-Distamycin-Derivaten, Taxanen und/oder Antimetaboliten
AR033992A1 (es) Asociaciones sinergicas de dalfopristina/quinupristina con cefpiroma las composiciones farmaceuticas que los contienen y el kit de presentacion de dicha asociacion
PT1351680E (pt) Utilizacao de anetole-ditioletiona na prevencao e tratamento da tenotoxicidade induzida por um medicamento
CO5280204A1 (es) Uso de glutamina para la prevencion de la diarrea de inicio tardio inducida por irinotecan

Legal Events

Date Code Title Description
FC Refusal
FC Refusal